Circulation, Vol 71, 699-708, Copyright © 1985 by American Heart Association
E Falk
Extensive microscopic examination of epicardial arteries and myocardium was
performed in 25 cases of sudden death due to acute coronary thrombosis.
Eighty-one percent of the thrombi had a layered structure with thrombus
material of differing age, indicating that they were formed successively by
repeated mural deposits that caused progressive luminal narrowing over an
extended period of time. This episodic growth of the thrombus was
accompanied by intermittent fragmentation of thrombus in 73% of the cases,
with peripheral embolization causing microembolic occlusion of small
intramyocardial arteries associated with microinfarcts. The period of
unstable angina before the final heart attack was, in all but one of 15
patients, characterized by such an ongoing thrombotic process in a major
coronary artery where recurrent mural thrombus formation seemed to have
alternated with intermittent thrombus fragmentation. The culmination of
this "dynamic" thrombotic process in total vascular occlusion caused the
final infarction and/or sudden death.
ARTICLES
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion
This article has been cited by other articles:
![]() |
R. S. Schwartz, A. Burke, A. Farb, D. Kaye, J. R. Lesser, T. D. Henry, and R. Virmani Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2167 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel Coronary Microembolization: From Bedside to Bench and Back to Bedside Circulation, November 3, 2009; 120(18): 1822 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abdel-Aty, M. Cocker, C. Meek, J. V. Tyberg, and M. G. Friedrich Edema as a very early marker for acute myocardial ischemia a cardiovascular magnetic resonance study. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1194 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carlsson, M. Wilson, A. J. Martin, and M. Saeed Myocardial Microinfarction after Coronary Microembolization in Swine: MR Imaging Characterization Radiology, March 1, 2009; 250(3): 703 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Breuckmann, K. Nassenstein, C. Bucher, I. Konietzka, G. Kaiser, T. Konorza, C. Naber, A. Skyschally, P. Gres, G. Heusch, et al. Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 121 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nassenstein, F. Breuckmann, C. Bucher, G. Kaiser, T. Konorza, L. Schafer, I. Konietzka, A. de Greiff, G. Heusch, R. Erbel, et al. How Much Myocardial Damage Is Necessary to Enable Detection of Focal Late Gadolinium Enhancement at Cardiac MR Imaging? Radiology, December 1, 2008; 249(3): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gibson, Y. B. Pride, J. L. Buros, E. Lord, A. Shui, S. A. Murphy, D. S. Pinto, P. J. Zimetbaum, M. S. Sabatine, C. P. Cannon, et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 546 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660. [Full Text] [PDF] |
||||
![]() |
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart J., April 1, 2007; 28(7): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction Circ. Res., January 5, 2007; 100(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grabherr, V. Djonov, A. Friess, M. J. Thali, G. Ranner, P. Vock, and R. Dirnhofer Postmortem angiography after vascular perfusion with diesel oil and a lipophilic contrast agent. Am. J. Roentgenol., November 1, 2006; 187(5): W515 - W523. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stone and H. D. Aronow Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy Mayo Clin. Proc., May 1, 2006; 81(5): 641 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, W. Zhang, Y. Zhang, Y. Yang, L. Sun, S. Hu, J. Chen, C. Zhang, Y. Zheng, Y. Zhen, et al. VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) Circulation, March 28, 2006; 113(12): 1615 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Poole-Wilson, A. Jacques, and A. Lyon Treatment of angina: a commentary on new therapeutic approaches Eur. Heart J. Suppl., February 1, 2006; 8(suppl_A): A20 - A25. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 8: Stabilization of the Patient With Acute Coronary Syndromes Circulation, December 13, 2005; 112(24_suppl): IV-89 - IV-110. [Full Text] [PDF] |
||||
![]() |
C. Heeschen Biomarkers in acute coronary syndromes and their role in diabetic patients Diabetes and Vascular Disease Research, October 1, 2005; 2(3): 122 - 127. [Abstract] [PDF] |
||||
![]() |
M. Sirol, V. Fuster, J. J. Badimon, J. T. Fallon, J.-F. Toussaint, and Z. A. Fayad Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent Circulation, September 13, 2005; 112(11): 1594 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gick, N. Jander, H.-P. Bestehorn, R.-P. Kienzle, M. Ferenc, K. Werner, T. Comberg, K. Peitz, D. Zohlnhofer, V. Bassignana, et al. Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size After Primary Percutaneous Catheter Intervention in Myocardial Infarction With and Without ST-Segment Elevation Circulation, September 6, 2005; 112(10): 1462 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby and P. Theroux Pathophysiology of Coronary Artery Disease Circulation, June 28, 2005; 111(25): 3481 - 3488. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z.H. Rittersma, A. C. van der Wal, K. T. Koch, J. J. Piek, J. P.S. Henriques, K. J. Mulder, J. P.H.M. Ploegmakers, M. Meesterman, and R. J. de Winter Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis: A Pathological Thrombectomy Study in Primary Percutaneous Coronary Intervention Circulation, March 8, 2005; 111(9): 1160 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Monaco, E. Rossi, D. Milazzo, F. Citterio, F. Ginnetti, G. D'Onofrio, D. Cianflone, F. Crea, L. M. Biasucci, and A. Maseri Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden J. Am. Coll. Cardiol., January 18, 2005; 45(2): 238 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamashita, E. Furukoji, K. Marutsuka, K. Hatakeyama, H. Yamamoto, S. Tamura, Y. Ikeda, A. Sumiyoshi, and Y. Asada Increased Vascular Wall Thrombogenicity Combined With Reduced Blood Flow Promotes Occlusive Thrombus Formation in Rabbit Femoral Artery Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2420 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Malyar, L. O. Lerman, M. Gossl, P. E. Beighley, and E. L. Ritman Relation of Nonperfused Myocardial Volume and Surface Area to Left Ventricular Performance in Coronary Microembolization Circulation, October 5, 2004; 110(14): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C H Lee, P de Feyter, P W Serruys, F Saia, P A Lemos, D Goedhart, P R Soares, V A W M Umans, M Ciccone, and M Cortellaro Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS) Heart, October 1, 2004; 90(10): 1156 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
B L Norgaard, K Andersen, K Thygesen, J Ravkilde, P Abrahamsson, L Grip, and M Dellborg Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring Heart, July 1, 2004; 90(7): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, M. Sakuma, A. C. Zago, X. Zhang, C. Shi, L. Leng, Y. Mizue, R. Bucala, and D. I. Simon Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rubenstein, A. V. Finn, R. C. Leinbach, S. Hollenbach, H. T. Aretz, R. Virmani, and H. K. Gold Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury J. Am. Coll. Cardiol., January 21, 2004; 43(2): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomoda and N. Aoki Coronary Blood Flow in Evolving Myocardial Infarction Preceded by Preinfarction Angina: A Critical Reevaluation of Preconditioning Effects in Clinical Cases Angiology, January 1, 2004; 55(1): 9 - 15. [Abstract] [PDF] |
||||
![]() |
M K Sinha, D Roy, D C Gaze, P O Collinson, and J-C Kaski Role of "Ischemia Modified Albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes Emerg. Med. J., January 1, 2004; 21(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Sobel, D. J. Taatjes, and D. J. Schneider Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 1979 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ardissino, P. A. Merlini, K. A. Bauer, M. Galvani, F. Ottani, F. Franchi, F. Bertocchi, R. D. Rosenberg, and P. M. Mannucci Coagulation activation and long-term outcome in acute coronary syndromes Blood, October 15, 2003; 102(8): 2731 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Falk and L Thuesen Pathology of coronary microembolisation and no reflow Heart, September 1, 2003; 89(9): 983 - 985. [Full Text] [PDF] |
||||
![]() |
R Erbel Spontaneous and interventional coronary microembolisation Heart, September 1, 2003; 89(9): 986 - 989. [Full Text] [PDF] |
||||
![]() |
T.-T. Hong, E. M. Driscoll, A. J. White, A. Sherigill, T. A. Giboulot, and B. R. Lucchesi Glycoprotein IIb/IIIa Receptor Antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-{[2-({4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl}amino)acetyl]amino}propanoic Acid Dihydrochloride (CRL42796), in Combination with Aspirin and/or Enoxaparin, Prevents Coronary Artery Rethrombosis after Successful Thrombolytic Treatment by Recombinant Tissue Plasminogen Activator J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heper and M. Bayraktaroglu The Importance of von Willebrand Factor Level and Heart Rate Changes in Acute Coronary Syndromes: A Comparison with Chronic Ischemic Conditions Angiology, May 1, 2003; 54(3): 287 - 299. [Abstract] [PDF] |
||||
![]() |
C. Heeschen, S. Dimmeler, C. W. Hamm, S. Fichtlscherer, E. Boersma, M. L. Simoons, A. M. Zeiher, and for the CAPTURE Study Investigators Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes Circulation, April 29, 2003; 107(16): 2109 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mohlenkamp, P. E Beighley, E. A Pfeifer, T. R Behrenbeck, P. F Sheedy II, and E. L Ritman Intramyocardial blood volume, perfusion and transit time in response to embolization of different sized microvessels Cardiovasc Res, March 1, 2003; 57(3): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Newby, B. U. Goldmann, and E. M. Ohman Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 31S - 36S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Sobel, R. Frye, and K. M. Detre Burgeoning Dilemmas in the Management of Diabetes and Cardiovascular Disease: Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Circulation, February 4, 2003; 107(4): 636 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Task Force on the Management of Acute Myocardi, F. Van de Werf, D. Ardissino, A. Betriu, D. V. Cokkinos, E. Falk, K. A.A. Fox, D. Julian, M. Lengyel, F.-J. Neumann, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation Eur. Heart J., January 1, 2003; 24(1): 28 - 66. [Full Text] [PDF] |
||||
![]() |
F Burzotta, M Hamon, R Sabatier, F Prati, A Boccanelli, and G Grollier Large intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosis Heart, December 1, 2002; 88(5): e6 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, H. Ito, K. Iwakura, S. Kawano, M. Ikushima, T. Masuyama, T. Ogihara, and K. Fujii Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1755 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Sposito and M. J. Chapman Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1524 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knottenbelt, P. J. Brennan, T. W. Meade, and for the Medical Research Council's General Practic Antithrombotic Treatment and the Incidence of Angina Pectoris Arch Intern Med, April 22, 2002; 162(8): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller-Bardorff, B. Weidtmann, E. Giannitsis, V. Kurowski, and H. A. Katus Release Kinetics of Cardiac Troponin T in Survivors of Confirmed Severe Pulmonary Embolism Clin. Chem., April 1, 2002; 48(4): 673 - 675. [Full Text] [PDF] |
||||
![]() |
L. Sanchez de Miguel, M. a M. Arriero, J. Farre, P. Jimenez, A. Garcia-Mendez, T. de Frutos, A. Jimenez, R. Garcia, F. Cabestrero, J. Gomez, et al. Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms J. Am. Coll. Cardiol., March 6, 2002; 39(5): 818 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maseri and D. Cianflone Inflammation in acute coronary syndromes Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B8 - B13. [Abstract] [PDF] |
||||
![]() |
J. A. Barrabes, D. Garcia-Dorado, M. Mirabet, R.-M. Lidon, B. Soriano, M. Ruiz-Meana, P. Pizcueta, J. Blanco, Y. Puigfel, and J. Soler-Soler Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs J. Am. Coll. Cardiol., January 2, 2002; 39(1): 157 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Quinn and D. J. Moliterno Troponins in Acute Coronary Syndromes: More TACTICS for an Early Invasive Strategy JAMA, November 21, 2001; 286(19): 2461 - 2462. [Full Text] [PDF] |
||||
![]() |
D.J Patel, A.H Gomma, C.J Knight, D.A Mulcahy, C.A Wright, H.J Purcell, and K.M Fox Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina?. An observational study of myocardial ischaemia and its relation to coronary anatomy Eur. Heart J., November 1, 2001; 22(21): 1991 - 1996. [Abstract] [PDF] |
||||
![]() |
D. Ardissino, P. A. Merlini, K. A. Bauer, E. Bramucci, M. Ferrario, R. Coppola, R. Fetiveau, S. Lucreziotti, R. D. Rosenberg, and P. M. Mannucci Thrombogenic potential of human coronary atherosclerotic plaques Blood, November 1, 2001; 98(9): 2726 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmermund and R. Erbel Unstable Coronary Plaque and Its Relation to Coronary Calcium Circulation, October 2, 2001; 104(14): 1682 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomoda and N. Aoki Pathophysiology of Early Coronary Angioplasty with Stenting on Non-Q-Wave vs Q-Wave Myocardial Infarction Angiology, October 1, 2001; 52(10): 671 - 679. [Abstract] [PDF] |
||||
![]() |
S. P. SCHULMAN and H. E. FESSLER Management of Acute Coronary Syndromes Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 917 - 922. [Full Text] [PDF] |
||||
![]() |
E. Giannitsis, M. Muller-Bardorff, S. Lehrke, U. Wiegand, R. Tolg, B. Weidtmann, F. Hartmann, G. Richardt, and H. A. Katus Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation, August 7, 2001; 104(6): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. Bentzon and E. Falk Coronary plaques calling for action -- why, where and how many? Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I3 - I9. [Abstract] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Arterioscler Thromb Vasc Biol, July 1, 2001; 21 (7): e9 - e9. [Full Text] [PDF] |
||||
![]() |
A. G. G. Turpie and E. M. Antman Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes Arch Intern Med, June 25, 2001; 161(12): 1484 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Circulation, June 19, 2001; 103(24): 2994 - 3018. [Full Text] [PDF] |
||||
![]() |
C.W. Hamm GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A14 - A20. [Abstract] [PDF] |
||||
![]() |
G. N. Levine, M. N. Ali, and A. I. Schafer Antithrombotic Therapy in Patients With Acute Coronary Syndromes Arch Intern Med, April 9, 2001; 161(7): 937 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
Randomized Trial of Aspirin, Sibrafiban, or Both for Secondary Prevention After Acute Coronary Syndromes Circulation, April 3, 2001; 103(13): 1727 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Praticò, C. Tillmann, Z.-B. Zhang, H. Li, and G. A. FitzGerald Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice PNAS, March 1, 2001; (2001) 61607398. [Abstract] [Full Text] |
||||
![]() |
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides The Genesis of Atherosclerosis and Risk Factors: A Review Angiology, February 1, 2001; 52(2): 89 - 98. [Abstract] [PDF] |
||||
![]() |
S.K.S. Lairikyengbam, A.G. Davies, and M.H. Anderson Present treatment options for unstable angina and non-Q-wave myocardial infarction QJM, January 1, 2001; 94(1): 5 - 11. [Full Text] [PDF] |
||||
![]() |
K. M. Akkerhuis, K.-L. Neuhaus, R. G. Wilcox, A. Vahanian, J.-L. Boland, J. Hoffmann, T. Baardman, G. Nehmiz, U. Roth, A. P. J. Klootwijk, et al. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study Eur. Heart J., December 2, 2000; 21(24): 2042 - 2055. [Abstract] [PDF] |
||||
![]() |
H. Dorge, T. Neumann, M. Behrends, A. Skyschally, R. Schulz, C. Kasper, R. Erbel, and G. Heusch Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2587 - H2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cox, R. Smith, M. Quinn, P. Theroux, P. Crean, and D. J. Fitzgerald Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1514 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bjessmo, N. Hammar, E. Sandberg, and T. Ivert Reduced risk of coronary artery bypass surgery for unstable angina during a 6-year period Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 388 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Goldstein, D. Demetriou, C. L. Grines, M. Pica, M. Shoukfeh, and W. W. O'Neill Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction N. Engl. J. Med., September 28, 2000; 343(13): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Barrabes, D. Garcia-Dorado, B. Soriano, J. Solares, Y. Puigfel, L. Trobo, A. Garcia-Lafuente, and J. Soler-Soler Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization Cardiovasc Res, August 1, 2000; 47(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Queen, B. Xu, K. Horinouchi, I. Fisher, and A. Ferro {beta}2-Adrenoceptors Activate Nitric Oxide Synthase in Human Platelets Circ. Res., July 7, 2000; 87(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm and E. Braunwald A Classification of Unstable Angina Revisited Circulation, July 4, 2000; 102(1): 118 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Erbel and G. Heusch Coronary microembolization J. Am. Coll. Cardiol., July 1, 2000; 36(1): 22 - 24. [Full Text] [PDF] |
||||
![]() |
K. P. Rentrop Thrombi in Acute Coronary Syndromes : Revisited and Revised Circulation, April 4, 2000; 101(13): 1619 - 1626. [Full Text] [PDF] |
||||
![]() |
J. Ravkilde Risk Stratification in Acute Coronary Syndrome Using Cardiac Troponin I Clin. Chem., April 1, 2000; 46(4): 443 - 444. [Full Text] [PDF] |
||||
![]() |
M. J Davies CORONARY DISEASE: The pathophysiology of acute coronary syndromes Heart, March 1, 2000; 83(3): 361 - 366. [Full Text] |
||||
![]() |
A. Brodison, R. Katira, R. S More, and A. Chauhan Current practice: Antiplatelet use in interventional cardiology Postgrad. Med. J., February 1, 2000; 76(892): 70 - 79. [Abstract] [Full Text] |
||||
![]() |
J. A. Ambrose and G. Dangas Unstable Angina: Current Concepts of Pathogenesis and Treatment Arch Intern Med, January 10, 2000; 160(1): 25 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.W. Hamm Unstable angina: the breakthrough Eur. Heart J., November 1, 1999; 20(21): 1517 - 1519. [PDF] |
||||
![]() |
X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Circulation, October 12, 1999; 100(15): 1609 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Petaja, E. Pesonen, J. A. Fernandez, A. E. Vento, O. J. Ramo, and J. H. Griffin CARDIOPULMONARY BYPASS AND ACTIVATION OF ANTITHROMBOTIC PLASMA PROTEIN C J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grund, H. T. Sommerschild, T. Lyberg, K. A. Kirkeboen, and A. Ilebekk Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H533 - H542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Gyongyosi, P Yang, A Hassan, F Weidinger, H Domanovits, A Laggner, and D Glogar Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study Heart, July 1, 1999; 82(1): 68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Tselepis, J. A. Goudevenos, A. P. Tambaki, L. Michalis, C. S. Stroumbis, D. C. Tsoukatos, M. Elisaf, and D. A. Sideris Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy Cardiovasc Res, July 1, 1999; 43(1): 183 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Freedman, R. Sauter, E. M. Battinelli, K. Ault, C. Knowles, P. L. Huang, and J. Loscalzo Deficient Platelet-Derived Nitric Oxide and Enhanced Hemostasis in Mice Lacking the NOSIII Gene Circ. Res., June 25, 1999; 84(12): 1416 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1368 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiechl and J. Willeit The Natural Course of Atherosclerosis : Part I: Incidence and Progression Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1484 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Ge, F Chirillo, J Schwedtmann, G Görge, M Haude, D Baumgart, V Shah, C von Birgelen, S Sack, H Boudoulas, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound Heart, June 1, 1999; 81(6): 621 - 627. [Abstract] [Full Text] |
||||
![]() |
C. W. Hamm, C. Heeschen, B. Goldmann, A. Vahanian, J. Adgey, C. M. Miguel, W. Rutsch, J. Berger, J. Kootstra, M. L. Simoons, et al. Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels N. Engl. J. Med., May 27, 1999; 340(21): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Sobel Increased Plasminogen Activator Inhibitor-1 and Vasculopathy : A Reconcilable Paradox Circulation, May 18, 1999; 99(19): 2496 - 2498. [Full Text] [PDF] |
||||
![]() |
Y.-H. Li, J.-K. Teng, W.-C. Tsai, L.-M. Tsai, L.-J. Lin, H.-R. Guo, and J.-H. Chen Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1543 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Badimon, M. Lettino, V. Toschi, V. Fuster, M. Berrozpe, J. H. Chesebro, and L. Badimon Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic Plaques : Effects of Tissue Factor Pathway Inhibitor on Plaque Thrombogenicity Under Flow Conditions Circulation, April 13, 1999; 99(14): 1780 - 1787. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |